Showing results (211-220 of 275) with videos related to
Sort By:
Pageof 28
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 25, 2006
Enzyme source effects on CYP2C9 kinetics and inhibitionVikas Kumar, Dan A Rock, Chad J Warren, et al.Placenta|April 12, 2002
Localization of the extracellular Ca(2+)-sensing receptor in the human placentaR A Bradbury, J Cropley, O Kifor, et al.Journal of Analytical Toxicology|May 1, 2001
Stability of benzodiazepines in formaldehyde solutionsT S Tracy, B F Rybeck, D G James, et al.Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|May 21, 2015
The pathology of murine coxsackievirus B3 myocarditis: An in situ hybridization studyS Sato, A P Burke, W Benson, et al.Archives of Biochemistry and Biophysics|February 1, 2003
Activation of cytochrome P450 2C9-mediated metabolism: mechanistic evidence in support of kinetic observationsJ Matthew Hutzler, Larry C Wienkers, Jan L Wahlstrom, et al.British Journal of Clinical Pharmacology|December 4, 2003
Steady-state pharmacokinetics and pharmacodynamics of cysteamine bitartrate in paediatric nephropathic cystinosis patientsEric B Belldina, Mei Y Huang, Jerry A Schneider, et al.Journal of the American Chemical Society|January 16, 2019
Direct Enantio- and Diastereoselective Vinylogous Addition of Butenolides to Chromones Catalyzed by Zn-ProPhenolBarry M Trost, Elumalai Gnanamani, Christopher A Kalnmals, et al.Pharmacogenetics and Genomics|May 2, 2012
Effect of P450 oxidoreductase variants on the metabolism of model substrates mediated by CYP2C9.1, CYP2C9.2, and CYP2C9.3Murali Subramanian, Vishal Agrawal, Duanpen Sandee, et al.Biochemical Pharmacology|May 8, 2004
Differential activation of CYP2C9 variants by dapsoneMatthew A Hummel, Leslie J Dickmann, Allan E Rettie, et al.Journal of Medical Virology|August 10, 2000
Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in miceS Tracy, K Höfling, S Pirruccello, et al.Pageof 28